Background
The current therapies for vitiligo require long duration with often disappointing outcomes. 5‐Fluorouracil (5‐FU) is a chemotherapeutic agent approved for topical use in the treatment of several dermatologic conditions. Matrix metalloproteinase 2 (MMP2) is synthesized by keratinocytes during the epidermal remodeling process and has been found to help in melanocyte migration.
Aim
To investigate the efficacy and safety of flexible microneedling followed by application of 5‐FU in vitiligo treatment and to evaluate the immunohistochemical expression of MMP2 in involved skin in vitiligo patients before and after treatment.
Methods
Twenty patients presented with vitiligo were planned to receive one session every 2 weeks for 12 weeks of microneedling followed by 5‐FU application. Clinical response to therapy was evaluated by VASI score. Pre‐ and post‐treatment biopsies were taken from vitiliginous patches for MMP2 immunostaining.
Results
Fifteen patients (75%) responded to therapy with observed side effects such as pain, erythema, and hyperpigmentation of margins. The clinical response was more in young patients and those who have short disease duration. MMP2 was significantly increased in post‐treatment biopsy compared with the pretreatment one.
Conclusions
5‐Fluorouracil application after microneedling is effective in the treatment of vitiligo with 75% response, 60% patient satisfaction, and tolerable side effects. The improvement in vitiligo patients by microneedling and 5‐fluorouracil could be due to upregulation of MMP2 in affected vitiligo specimens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.